Selective GABA
B receptor agonist. Skeletal muscle relaxant. The more active enantiomer of (±)-Baclofen (Prod. No.
ALX-550-039).
Product Specification
| Alternative Name: | R-(+)-β-(Aminoethyl)-4-chlorobenzenepropanoic acid (free base), R-(+)-4-Amino-3-(4-chlorophenyl)butanoic acid (free base) |
| |
| Formula: | C10H12ClNO2 |
| |
| MW: | 213.7 |
| |
| Purity: | ≥98% (NMR, HPLC) |
| |
| Appearance: | White to off-white powder. |
| |
| CAS: | 69308-37-8 |
| |
| MI: | 14: 937 |
| |
| Solubility: | Soluble in 1M HCl (50mg/ml) or DMSO. |
| |
| Long Term Storage: | +4°C |
| |
Please mouse over
Product Literature References
A novel cause of intrathecal baclofen overdosage: lessons to be learnt: C. Dalton, et al.; Clin. Rehabil.
22, 188 (2008),
Abstract;
Skeletal muscle relaxants: S. See & R. Ginzburg; Pharmacotherapy
28, 207 (2008),
Abstract;
Effects of GABA(B) receptor ligands in animal tests of depression and anxiety: M. Frankowska, et al.; Pharmacol. Rep.
59, 645 (2007),
Abstract;
Effects of phaclofen and the enantiomers of baclofen on cardiovascular responses to intrathecal administration of L- and D-baclofen in the rat: Y.G. Hong & J.L. Henry; Eur. J. Pharmacol.
196, 267 (1991),
Abstract;
Comparative stereostructure-activity studies on GABAA and GABAB receptor sites and GABA uptake using rat brain membrane preparations: E. Flach, et al.; J. Neurochem.
47, 898 (1986),
Abstract;
3-(p-Chlorophenyl)-4-aminobutanoic acid--resolution into enantiomers and pharmacological activity: B. Witczuk, et al.; Pol. J. Pharmacol. Pharm.
32, 187 (1980),
Abstract;